Journal Article

An Approach for Engineering Peptides for Competitive Inhibition of the SARS-COV-2 Spike Protein

de Melo-Minardi, Raquel C., Bastos, Luana Luiza, Mariano, Diego, Silva, Juliana Rodrigues Pereira, Sabino, Adriano de Paula, de Abreu, Ana Paula, de Oliveira, Leandro Morais, Carvalho, Frederico Chaves

2024

Overview

SARS-CoV-2 is the virus responsible for a respiratory disease called COVID-19 that devastated global public health. Since 2020, there has been an intense effort by the scientific community to develop safe and effective prophylactic and therapeutic agents against this disease. In this context, peptides have emerged as an alternative for inhibiting the causative agent. However, designing peptides that bind efficiently is still an open challenge. Here, we show an algorithm for peptide engineering. Our strategy consists of starting with a peptide whose structure is similar to the interaction region of the human ACE2 protein with the SPIKE protein, which is important for SARS-COV-2 infection. Our methodology is based on a genetic algorithm performing systematic steps of random mutation, protein–peptide docking (using the PyRosetta library) and selecting the best-optimized peptides based on the contacts made at the peptide–protein interface. We performed three case studies to evaluate the tool parameters and compared our results with proposals presented in the literature. Additionally, we performed molecular dynamics (MD) simulations (three systems, 200 ns each) to probe whether our suggested peptides could interact with the spike protein. Our results suggest that our methodology could be a good strategy for designing peptides.

• Publisher: MDPI AG
• Subject: Algorithms / Case studies / COVID-19 / COVID-19 vaccines / docking / Enzymes / Genomes / Glycoproteins / Health aspects / Humans / Molecular dynamics / Mutation / Pandemics / Peptides / Peptides - pharmacology / POTTER / Proteins / protein–peptide interactions / Respiratory tract diseases / RNA polymerase / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2 / Spike Glycoprotein, Coronavirus / Viral infections